E-ISSN 2149-388X | ISSN 2149-0430
 
2024, Vol: 10, Issue: 1
10 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Letter to the Editor 


Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?

Oluwanisola Akanji Onigbinde.


Cited By:1

Abstract
Since late December 2019 to date, the world has continued in the fight against the recent most dreaded coronavirus, severe acute respiratory syndrome 2 (SARS-CoV-2) that is ravaging the world. With the daily geometric increased in infected cases and death toll globally, it was predicted that Africa will suffer the most from the havoc of the coronavirus disease 2019 (COVID-19) pandemic. This prediction could be traced to the dilapidated health care delivery systems, overcrowding, and the high rate of corruption in the continent. However, the claws of this virus seem to have spared the shores of Africa as the death toll in this continent is too low if compared with developed countries with state-of-the-earth facilities. This has led to Africans claim of immunity or resistance to SARS-CoV-2 and that the virus is a 'White man's virus'. Are Africans truly immune to SARS-CoV-2? Should this self-acclaimed immunity or resistance be explored or ignored? Hence this study.

Key words: SARS-CoV-2, Africa, immunity, resistance, COVID-19


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Oluwanisola Akanji Onigbinde
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336

Web Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. https://www.ulutasmedicaljournal.com/?mno=57378 [Access: March 06, 2024]. doi:10.5455/umj.20210219111336

AMA (American Medical Association) Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336


Vancouver/ICMJE Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. (2021), [cited March 06, 2024]; 7(2): 141-144. doi:10.5455/umj.20210219111336


Harvard Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J, 7 (2), 141-144. doi:10.5455/umj.20210219111336


Turabian Style

Oluwanisola Akanji Onigbinde. 2021. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336


Chicago Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7 (2021), 141-144. doi:10.5455/umj.20210219111336


MLA (The Modern Language Association) Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7.2 (2021), 141-144. Print. doi:10.5455/umj.20210219111336


APA (American Psychological Association) Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writin ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.